Review



hcc liver diseases  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    OriGene hcc liver diseases
    Figure 5. Tissue distribution of HRG in normal human tissues and normal and diseased livers. A, Distribution of human HRG mRNA in nor- mal human tissues. (a) commercially available cDNA panel (normalized to GAPDH) from 48 different normal human tissues was tested by qPCR for relative abundance of HRG mRNA. (b) HRG mRNA levels are decreased in human <t>HCC.</t> HRG mRNA levels were quantified by qPCR in cDNA from samples of eight normal livers, 34 HCC tissues from different stages (seven samples Stage I, eight samples of Stages II and IIIA, three samples of Stage IV) and 12 b <t>non-HCC</t> <t>liver</t> disease (LD) tissues. Relative folds of mRNA expression levels between normal livers and the respective stages of HCC or non-HCC liver disease were calculated according to the DDCt method using normalization to TBP. The mean level of HRG mRNA expression in normal livers was set to 1.0.
    Hcc Liver Diseases, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+liver+diseases/pm25363753-75-31-34?v=OriGene
    Average 93 stars, based on 14 article reviews
    hcc liver diseases - by Bioz Stars, 2026-07
    93/100 stars

    Images

    1) Product Images from "The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein."

    Article Title: The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein.

    Journal: International journal of cancer

    doi: 10.1002/ijc.29312

    Figure 5. Tissue distribution of HRG in normal human tissues and normal and diseased livers. A, Distribution of human HRG mRNA in nor- mal human tissues. (a) commercially available cDNA panel (normalized to GAPDH) from 48 different normal human tissues was tested by qPCR for relative abundance of HRG mRNA. (b) HRG mRNA levels are decreased in human HCC. HRG mRNA levels were quantified by qPCR in cDNA from samples of eight normal livers, 34 HCC tissues from different stages (seven samples Stage I, eight samples of Stages II and IIIA, three samples of Stage IV) and 12 b non-HCC liver disease (LD) tissues. Relative folds of mRNA expression levels between normal livers and the respective stages of HCC or non-HCC liver disease were calculated according to the DDCt method using normalization to TBP. The mean level of HRG mRNA expression in normal livers was set to 1.0.
    Figure Legend Snippet: Figure 5. Tissue distribution of HRG in normal human tissues and normal and diseased livers. A, Distribution of human HRG mRNA in nor- mal human tissues. (a) commercially available cDNA panel (normalized to GAPDH) from 48 different normal human tissues was tested by qPCR for relative abundance of HRG mRNA. (b) HRG mRNA levels are decreased in human HCC. HRG mRNA levels were quantified by qPCR in cDNA from samples of eight normal livers, 34 HCC tissues from different stages (seven samples Stage I, eight samples of Stages II and IIIA, three samples of Stage IV) and 12 b non-HCC liver disease (LD) tissues. Relative folds of mRNA expression levels between normal livers and the respective stages of HCC or non-HCC liver disease were calculated according to the DDCt method using normalization to TBP. The mean level of HRG mRNA expression in normal livers was set to 1.0.

    Techniques Used: Expressing



    Similar Products

    compounds for prevention and treatment of hcv infection, liver disease and hcc  (Inserm Transfert)
    90
    Inserm Transfert compounds for prevention and treatment of hcv infection, liver disease and hcc
    Compounds For Prevention And Treatment Of Hcv Infection, Liver Disease And Hcc, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+liver+diseases/pmc07226751-489-29-0?v=Inserm+Transfert
    Average 90 stars, based on 1 article reviews
    compounds for prevention and treatment of hcv infection, liver disease and hcc - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    hcc liver diseases  (OriGene)
    93
    OriGene hcc liver diseases
    Figure 5. Tissue distribution of HRG in normal human tissues and normal and diseased livers. A, Distribution of human HRG mRNA in nor- mal human tissues. (a) commercially available cDNA panel (normalized to GAPDH) from 48 different normal human tissues was tested by qPCR for relative abundance of HRG mRNA. (b) HRG mRNA levels are decreased in human <t>HCC.</t> HRG mRNA levels were quantified by qPCR in cDNA from samples of eight normal livers, 34 HCC tissues from different stages (seven samples Stage I, eight samples of Stages II and IIIA, three samples of Stage IV) and 12 b <t>non-HCC</t> <t>liver</t> disease (LD) tissues. Relative folds of mRNA expression levels between normal livers and the respective stages of HCC or non-HCC liver disease were calculated according to the DDCt method using normalization to TBP. The mean level of HRG mRNA expression in normal livers was set to 1.0.
    Hcc Liver Diseases, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hcc+liver+diseases/pm25363753-75-31-34?v=OriGene
    Average 93 stars, based on 1 article reviews
    hcc liver diseases - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 5. Tissue distribution of HRG in normal human tissues and normal and diseased livers. A, Distribution of human HRG mRNA in nor- mal human tissues. (a) commercially available cDNA panel (normalized to GAPDH) from 48 different normal human tissues was tested by qPCR for relative abundance of HRG mRNA. (b) HRG mRNA levels are decreased in human HCC. HRG mRNA levels were quantified by qPCR in cDNA from samples of eight normal livers, 34 HCC tissues from different stages (seven samples Stage I, eight samples of Stages II and IIIA, three samples of Stage IV) and 12 b non-HCC liver disease (LD) tissues. Relative folds of mRNA expression levels between normal livers and the respective stages of HCC or non-HCC liver disease were calculated according to the DDCt method using normalization to TBP. The mean level of HRG mRNA expression in normal livers was set to 1.0.

    Journal: International journal of cancer

    Article Title: The nuclear bile acid receptor FXR controls the liver derived tumor suppressor histidine-rich glycoprotein.

    doi: 10.1002/ijc.29312

    Figure Lengend Snippet: Figure 5. Tissue distribution of HRG in normal human tissues and normal and diseased livers. A, Distribution of human HRG mRNA in nor- mal human tissues. (a) commercially available cDNA panel (normalized to GAPDH) from 48 different normal human tissues was tested by qPCR for relative abundance of HRG mRNA. (b) HRG mRNA levels are decreased in human HCC. HRG mRNA levels were quantified by qPCR in cDNA from samples of eight normal livers, 34 HCC tissues from different stages (seven samples Stage I, eight samples of Stages II and IIIA, three samples of Stage IV) and 12 b non-HCC liver disease (LD) tissues. Relative folds of mRNA expression levels between normal livers and the respective stages of HCC or non-HCC liver disease were calculated according to the DDCt method using normalization to TBP. The mean level of HRG mRNA expression in normal livers was set to 1.0.

    Article Snippet: The HCC samples included seven samples of Stage I HCC, eight samples of Stage II and IIIA HCC each, and three samples of Stage IV HCC and 13 samples of non HCC liver diseases (http://www.origene. com/assets/documents/TissueScan/LVRT101.xls).

    Techniques: Expressing